| Literature DB >> 33997129 |
Astrid Huesken1, Rainer Hoffmann1, Sofien Ayed1.
Abstract
PURPOSE: The guidelines on the management of patients with heart failure support intensive patient education on self-care. The present study aimed to evaluate the short-term and long-term impacts of a structured education provided by a qualified heart failure nurse on patients' self-care behavior and disease knowledge.Entities:
Keywords: Heart failure; Knowledge; Patient education; Self care
Year: 2021 PMID: 33997129 PMCID: PMC8105549 DOI: 10.1016/j.ijnss.2021.03.002
Source DB: PubMed Journal: Int J Nurs Sci ISSN: 2352-0132
Patient characteristics (n = 150).
| Characteristics | ||
|---|---|---|
| Gender | Male | 112 (74.7) |
| Female | 38 (25.3) | |
| Age, years, | 66 ± 12 (19–90) | |
| Marital status | Single | 34 (22.7) |
| Married | 92 (61.3) | |
| Widow | 24 (16.0) | |
| NYHA function class | Ⅰ | 13 (8.7) |
| Ⅱ | 13 (8.7) | |
| Ⅲ | 73 (48.7) | |
| Ⅳ | 28 (18.7) | |
| Not Known | 23 (15.3) | |
| Number of hospitalizations | 103 (68.7) | |
| Time since diagnosis of heart failure, days, | 41 (6–1,597) | |
| Heart failure category | HFrEF | 100 (66.7) |
| HFmEF | 41 (27.3) | |
| HFpEF | 9 (6.0) | |
| Ejection fraction, %, | 34.5 ± 10.2 | |
| Etiology | Ischemic heart disease | 59 (39.3) |
| Dilative cardiomyopathy | 65 (43.3) | |
| Hypertensive cardiomyopathy | 5 (3.3) | |
| Restrictive cardiomyopathy | 5 (3.3) | |
| Valvular heart disease | 10 (6.7) | |
| Non-compaction cardiomyopathy | 3 (2.0) | |
| Post myocarditis | 2 (0.7) | |
| Tako-Tsubo- cardiomyopathy | 1 (0.7) | |
| Prior myocardial infarction | 31 (20.6) | |
| Comorbidities | Hypertension | 130 (86.0) |
| Atrial fibrillation/atrial flutter | 67 (44.6) | |
| Chronic kidney disease | 31 (20.6) | |
| Diabetes | 47 (31.3) | |
| Chronic obstructive lung disease | 12 (8.0) | |
| Peripheral vascular disease | 10 (6.6) | |
| Medication | Beta receptor blocker | 142 (94.7) |
| ACE inhibitor | 94 (62.7) | |
| AT1 receptor antagonist | 23 (15.3) | |
| Neprilysin inhibitor | 29 (19.3) | |
| Mineralocorticoid receptor antagonist | 105 (70.0) | |
| Diuretic | 100 (66.7) | |
| Device system | ICD | 15 (10.0) |
| CRT | 18 (12.0) | |
Note: NYHA = New York Heart Association. HFrEF = heart failure reduced ejection fraction. HFmEF = heart failure intermediate ejection fraction. HFpEF = heart failure preserved ejection fraction. ACE = angiotensin-converting enzyme. AT1 receptor antagonist = angiotensin–II–receptor-subtype-1 antagonist. ICD = internal cardiac defibrillator. CRT = cardiac resynchronization therapy.
Answer score to the nine questions on self-care (EHFScB-9) and the six questions on patient disease knowledge.
| Item | Prior ( | After ( | Follow-up ( | After vs. Prior | Follow-up vs. Prior | |||
|---|---|---|---|---|---|---|---|---|
| Q1: I know the function of the heart | 2.49 ± 1.10 | 1.76 ± 0.80 | 2.06 ± 1.02 | −0.70 ± 1.02 | −9.94 | <0.001 | −9.45 | 0.009 |
| Q2: I know what heart failure means | 2.58 ± 1.21 | 1.68 ± 0.84 | 1.91 ± 1.03 | −0.87 ± 1.18 | −9.96 | <0.001 | −10.44 | <0.001 |
| Q3: I know the symptoms of heart failure | 3.16 ± 1.38 | 1.81 ± 0.99 | 2.17 ± 1.12 | −1.33 ± 1.32 | −13.18 | <0.001 | −12.21 | <0.001 |
| Q4: I know the causes of my heart failure | 3.65 ± 1.33 | 2.11 ± 1.09 | 2.47 ± 1.21 | −1.53 ± 1.43 | −14.43 | <0.001 | −13.16 | <0.001 |
| Q5: I feel adequately informed about my heart failure disease | 3.00 ± 1.27 | 1.53 ± 0.79 | 1.94 ± 1.07 | −1.45±1.32 | −14.50 | <0.001 | −13.25 | <0.001 |
| Q6: The effects of the drugs prescribed to me are known to me | 3.14 ± 1.28 | 1.85 ± 1.02 | 1.91 ± 1.00 | −1.29 ± 1.36 | −12.66 | <0.001 | −13.52 | <0.001 |
| Q7: I weigh myself every day | 3.66 ± 1.58 | 1.87 ± 1.26 | 2.34 ± 1.42 | −1.77 ± 1.64 | −14.97 | <0.001 | −13.67 | <0.001 |
| Q8: If my shortness of breath increases, I contact my doctor or nurse | 2.64 ± 1.38 | 1.50 ± 0.87 | 1.68 ± 1.02 | −1.15 ± 1.39 | −10.96 | <0.001 | −11.04 | <0.001 |
| Q9: If my feet/legs become more swollen than usual, I contact my doctor or my nurse | 2.55 ± 1.40 | 1.57 ± 1.01 | 1.82 ± 1.22 | −0.99 ± 1.54 | −9.38 | <0.001 | −9.49 | <0.001 |
| Q10: If I gain 2 kg in 3 days I contact my doctor or my nurse | 3.57 ± 1.56 | 1.57 ± 1.09 | 1.98 ± 1.36 | −2.00±1.57 | −16.91 | <0.001 | −14.93 | <0.001 |
| Q11: I do not drink more than 1.5–2.0 L/day | 2.51 ± 1.39 | 1.76 ± 1.00 | 2.06 ± 1.11 | −0.74 ± 1.32 | −8.71 | <0.001 | −8.90 | <0.001 |
| Q12: If I experience increased fatigue, I contact my doctor or my nurse | 3.05 ± 1.48 | 1.67 ± 1.04 | 2.09 ± 1.25 | −1.39 ± 1.46 | −12.51 | <0.001 | −11.14 | <0.001 |
| Q13: I eat a low salt diet | 3.07 ± 1.30 | 2.18 ± 1.07 | 2.31 ± 1.06 | −0.79±1.27 | −9.78 | <0.001 | −11.00 | <0.001 |
| Q14: I take my medication as prescribed | 1.26 ± 0.81 | 1.14 ± 0.49 | 1.19 ± 0.76 | −0.11 ± 0.74 | −3.80 | 0.1342 | −5.32 | 0.464 |
| Q15: I exercise regularly | 2.07 ± 1.12 | 1.68 ± 0.87 | 1.86 ± 1.16 | −0.39 ± 0.92 | −6.47 | 0.0035 | −7.04 | 0.632 |
Note: A total of 15 questions were provided in a patient questionnaire before an educational session (Prior), one day after the educational session (After), and at 6-month follow-up (Follow-up). HFScB = European Heart Failure Self-Care Behavior Scale.